Medikhronal - Darnitsa

General characteristics. Structure:

Package No. 1: active ingredient - glucose - 17,5 g;
excipient: polyvinylpirrolidone low-molecular medical.

package No. 2: active ingredients - the aminoacetic acid - 7 g, sodium formiate - 3,5 g;
excipient: polyvinylpirrolidone low-molecular medical.

Pharmacological properties:

Pharmacodynamics. Medikhronal-Darnitsa is pathogenetic means for treatment of an alcoholism. The mechanism of action is caused by influence on alcohol exchange, in particular binding of acetic aldehyde - an ethanol oxidation product. Drug strengthens synthesis of catecholamines, especially noradrenaline that improves mediation processes, stimulates a limbiko-reticular complex, increases functional activity of a cerebral cortex.

Pharmacokinetics. It is not described.

Indications to use:

Medikhronal-Darnitsa is recommended for removal of acute alcoholic and abstinent states and elimination of physical dependence at an alcoholism. It is applied also to secondary prevention of alcoholism.

Route of administration and doses:

Medikhronal-Darnits is appointed the adult inside after food, previously having dissolved contents of both packages (No. 1 and No. 2) in 1/2-3/4 glasses of warm water. The single dose makes 28,5 g (lump of components of both packages).
For removal of acute alcoholic and abstinent states drug is used in the 1st day by 1-2 times in a dose 28,5 g, in the next 2-3 days - on 28,5 g once a day.
At treatment of an alcoholism and in need of secondary prevention drug is appointed daily on one packaging (28,5 g) for 7 days, by only 3 courses with three-day breaks between them.

Features of use:

Any change of a dose of drug needs to be carried out under control of the doctor. Clinical data on safety of use of drug during the periods of pregnancy and feeding by a breast are absent.

Side effects:

Medikhronal-Darnitsa is well had. In some cases the skin itch at which emergence the dose of drug is reduced can be observed.

Interaction with other medicines:

Data on Medikhronala-Darnits's interaction with other medicines are absent.

Contraindications:

Severe forms of a diabetes mellitus.

Overdose:

About overdose of drug there were no messages.

Storage conditions:

To store in dry, protected from light and the place, unavailable to children. A period of validity - 3 years.

Issue conditions:

Without recipe

Packaging:

Packages from paper of a polyethylene covering (a package No. 1-17,8 of and a package No. 2-10,7 of) in 1 packaging.